426
Participants
Start Date
July 19, 2013
Primary Completion Date
April 10, 2015
Study Completion Date
August 31, 2017
Gadobutrol (Gadovist, Gadavist, BAY86-4875)
Participants received gadobutrol at the total approved standard dose of 0.1 millimole per kilogram body weight (mmol/kg BW) in 2 separate bolus injections: 0.05 mmol/kg BW at peak pharmacologic stress and 0.05 mmol/kg BW at rest via a power injector.
Lugano
Berlin
Berlin
Berlin
Marseille
Incheon
Göttingen
Saint-Etienne
Essen
Yangsan
Bonn
Minneapolis
Darmstadt
Stuttgart
Tübingen
Bad Krozingen
Leipzig
Auckland
Seoul
Seoul
Leicester
Liverpool
London
Lead Sponsor
Bayer
INDUSTRY